63 related articles for article (PubMed ID: 18783878)
41. A novel technique for selective NF-kappaB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion.
Hoffmann F; Sass G; Zillies J; Zahler S; Tiegs G; Hartkorn A; Fuchs S; Wagner J; Winter G; Coester C; Gerbes AL; Vollmar AM
Gut; 2009 Dec; 58(12):1670-8. PubMed ID: 19470497
[TBL] [Abstract][Full Text] [Related]
42. Nuclear factor-kappaB modulation in patients undergoing induction chemotherapy for acute myelogenous leukemia.
Strair RK; Gharibo M; Schaar D; Rubin A; Harrison J; Aisner J; Lin HC; Lin Y; Goodell L; Anand M; Balsara B; Dudek L; Rabson A; Medina DJ
Clin Cancer Res; 2008 Nov; 14(22):7564-8. PubMed ID: 19010875
[TBL] [Abstract][Full Text] [Related]
43. The tumour necrosis factor-alpha-mediated suppression of the CCAAT/enhancer binding protein-alpha gene transcription in hepatocytes involves inhibition of autoregulation.
Foka P; Singh NN; Salter RC; Ramji DP
Int J Biochem Cell Biol; 2009 May; 41(5):1189-97. PubMed ID: 19027873
[TBL] [Abstract][Full Text] [Related]
44. Hexamethylene bisacetamide can convert nonpermissive human cells to a permissive state for expressing the major immediate-early genes of human cytomegalovirus by up-regulating NF-kappaB activity.
Kitagawa R; Takahashi Y; Takahashi M; Imazu H; Yasuda M; Sadanari H; Tanaka J
Virology; 2009 Jan; 383(2):195-206. PubMed ID: 19027925
[TBL] [Abstract][Full Text] [Related]
45. Preparation and quantification of pseudotyped retroviral vector.
Yu H; Kwon YJ
Methods Mol Biol; 2008; 433():1-16. PubMed ID: 18679614
[TBL] [Abstract][Full Text] [Related]
46. Cell-Cell Fusion Mediated by Viruses and HERV-Derived Fusogens in Cancer Initiation and Progression.
Dittmar T; Weiler J; Luo T; Hass R
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771528
[TBL] [Abstract][Full Text] [Related]
47. An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate
Del Papa J; Petryk J; Bell JC; Parks RJ
Mol Ther Oncolytics; 2019 Sep; 14():107-120. PubMed ID: 31193718
[TBL] [Abstract][Full Text] [Related]
48. Fusogenic Viruses in Oncolytic Immunotherapy.
Krabbe T; Altomonte J
Cancers (Basel); 2018 Jun; 10(7):. PubMed ID: 29949934
[TBL] [Abstract][Full Text] [Related]
49. BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.
Kuang CM; Fu X; Hua YJ; Shuai WD; Ye ZH; Li Y; Peng QH; Li YZ; Chen S; Qian CN; Huang W; Liu RY
Cell Death Dis; 2017 Jun; 8(6):e2874. PubMed ID: 28617432
[TBL] [Abstract][Full Text] [Related]
50. Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents.
Del Papa J; Parks RJ
Viruses; 2017 Jan; 9(1):. PubMed ID: 28106842
[TBL] [Abstract][Full Text] [Related]
51. Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction.
Johnson KJ; Peng KW; Allen C; Russell SJ; Galanis E
Gene Ther; 2003 May; 10(9):725-32. PubMed ID: 12704411
[TBL] [Abstract][Full Text] [Related]
52. A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy.
Diaz RM; Bateman A; Emiliusen L; Fielding A; Trono D; Russell SJ; Vile RG
Gene Ther; 2000 Oct; 7(19):1656-63. PubMed ID: 11083474
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of NF-kappaB in fusogenic membrane glycoprotein causing HL-60 cell death: implications for acute myeloid leukemia.
Tan L; Jia H; Liu R; Wu J; Han H; Zuo Y; Yang S; Huang W
Cancer Lett; 2009 Jan; 273(1):114-21. PubMed ID: 18783878
[TBL] [Abstract][Full Text] [Related]
54. Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy.
Higuchi H; Bronk SF; Bateman A; Harrington K; Vile RG; Gores GJ
Cancer Res; 2000 Nov; 60(22):6396-402. PubMed ID: 11103804
[TBL] [Abstract][Full Text] [Related]
55. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
[TBL] [Abstract][Full Text] [Related]
56. Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer.
Lin EH; Salon C; Brambilla E; Lavillette D; Szecsi J; Cosset FL; Coll JL
Cancer Gene Ther; 2010 Apr; 17(4):256-65. PubMed ID: 19893593
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
